Coloplast ASCLPBF 72 Gross Margin % is 66.59% as of Mar. 2026, which is 2% below its 10-year median of 67.99. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $126.92 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Coloplast AS ranks better than 75.78% on this metric.
The historical rank and industry rank for Coloplast AS's Gross Margin % or its related term are showing as below:
CLPBF'
s Gross Margin % Range Over the Past 10 Years
Min: 66.64 Med: 67.99 Max: 68.78
Current: 67.46
During the past 13 years, the highestGross Margin % of Coloplast AS was 68.78%. The lowest was 66.64%. And the median was 67.99%.
CLPBF's Gross Margin % is ranked better than 75.78% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs CLPBF: 67.46
Coloplast AS had a gross margin of 66.59% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Coloplast AS was -0.20% per year.
Coloplast AS (OTCPK:CLPBF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Coloplast AS had a gross margin of 66.59% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Coloplast AS Gross Margin % Related Terms
Coloplast AS Gross Margin % Historical Data
* Premium members only.
The historical data trend for Coloplast AS's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLPBF vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Coloplast AS's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Coloplast AS's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Coloplast AS (CLPBF) has a Gross Margin % of 66.59% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Coloplast AS and its competitors. This is near median its historical median of 67.99. Over the past decade, Coloplast AS's Gross Margin % has ranged from 66.64 to 68.78. According to the industry distribution chart, Coloplast AS ranks #195 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 24.2%.
Is Coloplast AS's Gross Margin % too high?
Coloplast AS's current Gross Margin % of 66.59% is near median its 10-year median of 67.99. Over the past 10 years, this metric has ranged from a low of 66.64 to a high of 68.78. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Coloplast AS's value of 66.59% is 27.9% above this industry median. Based on the distribution chart, Coloplast AS ranks #195 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #195 out of 805 companies for Gross Margin %. This places Coloplast AS in the top 24% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.07. Coloplast AS's value of 66.59% is 27.9% above this benchmark. Historically, Coloplast AS's own Gross Margin % has ranged from 66.64 to 68.78 over the past decade. While the company's 10-year median is 67.99 vs. the industry median of 52.07, Coloplast AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coloplast AS's current Gross Margin % of 66.59% is 27.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current Gross Margin % is 66.59%, which is near median its own 10-year median of 67.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.92, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current Gross Margin % is 66.59%, which is near median its 10-year median of 67.99 and 27.9% above the Medical Devices & Instruments industry median of 52.07. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Gross Margin % is 66.59% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBF) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.92.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBF:
Gross Margin %: 66.59% (near median its 10-year median of 67.99)
GF Value™: $126.92 vs. price of $57.41 (54.8% below fair value)
Industry Position: 27.9% above the Medical Devices & Instruments median (#195 of 805)
No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score
Get the complete analysis for CLPBF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBF has been successfully added to your 
